Aphios Corporation - Product Pipeline Review - 2014

Published: Jul, 2014 | Pages: 54 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Aphios Corporation - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Aphios Corporation - Product Pipeline Review - 2014', provides an overview of the Aphios Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Aphios Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Aphios Corporation including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Aphios Corporation's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Aphios Corporation's pipeline products

Reasons to buy

- Evaluate Aphios Corporation's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Aphios Corporation in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Aphios Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Aphios Corporation and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Aphios Corporation
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Aphios Corporation and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Aphios Corporation Snapshot 6
Aphios Corporation Overview 6
Key Information 6
Key Facts 6
Aphios Corporation - Research and Development Overview 7
Key Therapeutic Areas 7
Aphios Corporation - Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products - Monotherapy 12
Pipeline Products - Partnered Products 13
Partnered Products/Combination Treatment Modalities 14
Aphios Corporation - Pipeline Products Glance 15
Aphios Corporation - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Phase I Products/Combination Treatment Modalities 16
Aphios Corporation - Early Stage Pipeline Products 17
Preclinical Products/Combination Treatment Modalities 17
Discovery Products/Combination Treatment Modalities 18
Aphios Corporation - Drug Profiles 19
APH-0703 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
APH-0812 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
AMPI-109 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
APH-0201 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
APH-0701 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
APH-0907 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
APH-0911 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
APH-0912 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Asterias 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
camptothecin nanosomal 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
dronabinol 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Frondoside A 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
HIV/AIDS Therapeutic Vaccine 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Hypericin 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Marinus 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
paclitaxel nanosomal 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
paclitaxel phospholipid nanosomal 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Sperol 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
APH-0202 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
APH-0804 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
APH-1305 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
APP-0205 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
APP-069 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
APP-309 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
APP-401 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
Aphios Corporation - Pipeline Analysis 44
Aphios Corporation - Pipeline Products by Target 44
Aphios Corporation - Pipeline Products by Route of Administration 46
Aphios Corporation - Pipeline Products by Molecule Type 47
Aphios Corporation - Pipeline Products by Mechanism of Action 48
Aphios Corporation - Recent Pipeline Updates 50
Aphios Corporation - Dormant Projects 51
Aphios Corporation - Locations And Subsidiaries 52
Head Office 52
Appendix 53
Methodology 53
Coverage 53
Secondary Research 53
Primary Research 53
Expert Panel Validation 53
Contact Us 54
Disclaimer 54

List of Tables
Aphios Corporation, Key Information 6
Aphios Corporation, Key Facts 6
Aphios Corporation - Pipeline by Indication, 2014 9
Aphios Corporation - Pipeline by Stage of Development, 2014 11
Aphios Corporation - Monotherapy Products in Pipeline, 2014 12
Aphios Corporation - Partnered Products in Pipeline, 2014 13
Aphios Corporation - Partnered Products/ Combination Treatment Modalities, 2014 14
Aphios Corporation - Phase II, 2014 15
Aphios Corporation - Phase I, 2014 16
Aphios Corporation - Preclinical, 2014 17
Aphios Corporation - Discovery, 2014 18
Aphios Corporation - Pipeline by Target, 2014 45
Aphios Corporation - Pipeline by Route of Administration, 2014 46
Aphios Corporation - Pipeline by Molecule Type, 2014 47
Aphios Corporation - Pipeline Products by Mechanism of Action, 2014 49
Aphios Corporation - Recent Pipeline Updates, 2014 50
Aphios Corporation - Dormant Developmental Projects,2014 51